• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.标准辐射剂量测定模型:介入放射科医生需要了解的内容。
Semin Intervent Radiol. 2021 Oct;38(4):405-411. doi: 10.1055/s-0041-1732323. Epub 2021 Oct 7.
2
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.使用MIRD剂量测定法和树脂微球进行钇-90放射性栓塞治疗。
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
3
Insights into handling and delivery of Y-90 radioembolization therapies.Y-90放射性栓塞治疗的操作与递送见解。
Front Nucl Med. 2023 Mar 21;3:1075782. doi: 10.3389/fnume.2023.1075782. eCollection 2023.
4
Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.钇-90放射性栓塞剂量学:介入放射科医生的概念
Tech Vasc Interv Radiol. 2019 Jun;22(2):100-111. doi: 10.1053/j.tvir.2019.02.011. Epub 2019 Feb 27.
5
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.钇-90放射性栓塞治疗肝细胞癌的历史与演变
J Clin Med. 2019 Jan 7;8(1):55. doi: 10.3390/jcm8010055.
6
Techniques to Optimize Radioembolization Tumor Coverage.优化放射性栓塞肿瘤覆盖范围的技术。
Semin Intervent Radiol. 2024 Mar 14;41(1):16-19. doi: 10.1055/s-0043-1778659. eCollection 2024 Feb.
7
Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.基于动脉特异性 SPECT/CT 分区建模的个体化预测剂量学指导下的安全有效的 90Y 放射性栓塞治疗
J Nucl Med. 2012 Apr;53(4):559-66. doi: 10.2967/jnumed.111.097469. Epub 2012 Feb 17.
8
Conventional Hepatic Volumetry May Lead to Inaccurate Segmental Yttrium-90 Radiation Dosimetry.常规肝脏体积测量可能导致钇-90 放射性剂量测定不准确。
Cardiovasc Intervent Radiol. 2021 Dec;44(12):1973-1985. doi: 10.1007/s00270-021-02898-y. Epub 2021 Aug 19.
9
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.使用钇-90微球近距离放射治疗进行肝恶性肿瘤放射性栓塞治疗的建议:放射性栓塞近距离放射治疗肿瘤学联盟的共识小组报告
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):13-23. doi: 10.1016/j.ijrobp.2006.11.060.
10
MIRD Pamphlet No. 29: MIRDy90-A Y Research Microsphere Dosimetry Tool.MIRD宣传册第29号:MIRDy90-A Y研究微球剂量测定工具。
J Nucl Med. 2024 Feb 22;65(5):794-802. doi: 10.2967/jnumed.123.266743.

引用本文的文献

1
Selective internal radiation with Y-90 resin microspheres (SIRT) for liver metastases of gastro-intestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor (TKI) therapy.使用Y-90树脂微球进行选择性内照射(SIRT)治疗对酪氨酸激酶抑制剂(TKI)治疗耐药的胃肠道间质瘤(GIST)肝转移灶
Br J Cancer. 2025 May;132(8):716-724. doi: 10.1038/s41416-025-02952-3. Epub 2025 Mar 5.
2
Transarterial Radioembolization for Management of Hepatocellular Carcinoma.经动脉放射栓塞治疗肝细胞癌。
Oncologist. 2024 Feb 2;29(2):117-122. doi: 10.1093/oncolo/oyad327.
3
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.Y90 在肝细胞癌治疗中的当代应用。
Hepatol Commun. 2023 Oct 2;7(10). doi: 10.1097/HC9.0000000000000288. eCollection 2023 Oct 1.
4
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.基于体素的剂量学预测树脂基 Y90 放射性栓塞治疗 HCC 患者的治疗反应及相关毒性:一项前瞻性、单臂研究。
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1743-1752. doi: 10.1007/s00259-023-06111-9. Epub 2023 Jan 18.
5
Applied Change Management in Interventional Radiology-Implementation of Percutaneous Thermal Ablation as an Additional Therapeutic Method for Small Renal Masses.介入放射学中的应用变革管理——将经皮热消融作为小肾肿块的一种额外治疗方法的实施
Diagnostics (Basel). 2022 May 24;12(6):1301. doi: 10.3390/diagnostics12061301.

本文引用的文献

1
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.国际推荐使用钇-90 树脂微球行原发性和转移性肝脏疾病的个性化选择性内放射治疗。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1570-1584. doi: 10.1007/s00259-020-05163-5. Epub 2021 Jan 12.
2
Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.钇-90放射性栓塞剂量学:实习生需要了解的内容。
Semin Intervent Radiol. 2020 Dec;37(5):543-554. doi: 10.1055/s-0040-1720954. Epub 2020 Dec 11.
3
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.个体化与标准剂量测定法在局部进展期肝细胞癌患者选择性内放射治疗中的应用(DOSISPHERE-01):一项随机、多中心、开放标签的 2 期试验。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7.
4
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.使用MIRD剂量测定法和树脂微球进行钇-90放射性栓塞治疗。
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
5
Planning dosimetry for Y radioembolization with glass microspheres: Evaluating the fidelity of Tc-MAA and partition model predictions.玻璃微球钇[90Y]放射性栓塞治疗的剂量学规划:评估99m锝标记大颗粒白蛋白(Tc-MAA)和分区模型预测的准确性
Med Phys. 2020 Oct;47(10):5333-5342. doi: 10.1002/mp.14452. Epub 2020 Sep 9.
6
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Y in the SARAH Study.SARAH 研究中钇[90Y]放射性微球内放射栓塞治疗肝细胞癌的肿瘤吸收剂量与生存和反应的关系。
Radiology. 2020 Sep;296(3):673-684. doi: 10.1148/radiol.2020191606. Epub 2020 Jun 30.
7
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.随机对照 SIRFLOX 试验中化疗联合或不联合选择性内放射治疗后结直肠癌肝转移的二次可切除性。
Br J Surg. 2019 Dec;106(13):1837-1846. doi: 10.1002/bjs.11283. Epub 2019 Aug 19.
8
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.联合选择性内部放射治疗和索拉非尼对晚期肝细胞癌患者生存的影响。
J Hepatol. 2019 Dec;71(6):1164-1174. doi: 10.1016/j.jhep.2019.08.006. Epub 2019 Aug 14.
9
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
10
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.SIRveNIB:索拉非尼对比选择性内放射治疗在亚太地区肝细胞癌患者中的应用。
J Clin Oncol. 2018 Jul 1;36(19):1913-1921. doi: 10.1200/JCO.2017.76.0892. Epub 2018 Mar 2.

标准辐射剂量测定模型:介入放射科医生需要了解的内容。

Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.

作者信息

Webster Linzi Arndt, Villalobos Alexander, Majdalany Bill S, Bercu Zachary L, Gandhi Ripal T, Kokabi Nima

机构信息

Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Miami Cardiac and Vascular Institute, Miami Cancer Institute, Miami, FL.

出版信息

Semin Intervent Radiol. 2021 Oct;38(4):405-411. doi: 10.1055/s-0041-1732323. Epub 2021 Oct 7.

DOI:10.1055/s-0041-1732323
PMID:34629706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497093/
Abstract

Thoughtful and accurate dosimetry is critical to obtain the safest and most efficacious yttrium-90 (Y90) radioembolization of primary and secondary liver cancers. Three dosimetry models are currently used in clinical practice, namely, body surface area model, medical internal radiation dose model, and the partition model. The objective of this review is to briefly outline the history behind Y90 dosimetry and the difference between the aforementioned models. When applying these three models to a single case, the differences between them are further demonstrated. Each dosimetry model in clinical practice has its own benefits and limitations. Therefore, it is incumbent upon practicing interventional radiologists to be aware of these differences to optimize treatment outcomes for their patients.

摘要

精确且周全的剂量测定对于实现原发性和继发性肝癌最安全、有效的钇-90(Y90)放射性栓塞治疗至关重要。目前临床实践中使用三种剂量测定模型,即体表面积模型、医学内照射剂量模型和分区模型。本综述的目的是简要概述Y90剂量测定背后的历史以及上述模型之间的差异。将这三种模型应用于单个病例时,它们之间的差异会进一步显现。临床实践中的每种剂量测定模型都有其自身的优点和局限性。因此,执业介入放射科医生有责任了解这些差异,以便为患者优化治疗效果。